2024年9月26日 · Nexlizet (bempedoic acid and ezetimibe) may be used to reduce LDL-C levels in adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH), alone or in combination with other LDL-C lowering therapies. Nexlizet should be used in addition to dietary changes.

NEXLIZET and NEXLETOL are the only oral nonstatins FDA approved to lower bad cholesterol, and to reduce the risk of heart attack and heart procedures, like stent placement or bypass surgery, in adults who are unable to take recommended statin treatment or are not taking a statin. Is NEXLIZET right for you?

2024年6月30日 · Find patient medical information for Nexlizet (bempedoic acid/ezetimibe) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

2020年11月16日 · Nexlizet则是获监管批准的第一个非他汀类、降胆固醇（LDL-C）复方药物。 用药方面，2个药物均推荐：每日口服一片、可与或不与食物同服。 当前，尽管接受标准护理治疗（包括他汀类药物），但仍有许多患者无法达到LDL-C目标。 这2款药物的上市，将为因HeFH而存在升高的心血管疾病风险的患者、以及LDL-C水平升高的ASCVD患者提供一个重要的治疗选择。 LDL-C是一种存在于人体内的蜡状脂肪样物质。 升高的LDL-C会促进动脉中LDL-C的堆积，并 …

NEXLIZET is used, with or without other cholesterol-lowering medicines, to reduce low-density lipoprotein (LDL, or bad cholesterol) in adults with high blood cholesterol levels called primary hyperlipidemia, including a type of high cholesterol called heterozygous familial hypercholesterolemia (HeFH).

NEXLIZET, a combination of bempedoic acid and ezetimibe, is indicated : As an adjunct to diet, alone or i n combination with other low -density lipoprotein cholesterol (LDL -C) lowering...

NEXLIZET is used, with or without other cholesterol-lowering medicines, to reduce low-density lipoprotein (LDL, or bad cholesterol) in adults with high blood cholesterol levels called primary hyperlipidemia, including a type of high cholesterol called heterozygous familial hypercholesterolemia (HeFH).

2020年2月27日 · Nexlizet 的活性药物成分则为 bempedoic acid和ezetimibe（伊折麦布） ，通过 抑制肝脏胆固醇合成和肠道吸收的互补机制来降低LDL-C 。

Discover NEXLIZET® and NEXLETOL®, approved to lower LDL-C and the risk of MI and coronary revascularization. See ISI and full prescribing information

Bempedoic acid/ezetimibe, sold under the brand name Nexlizet among others, is a fixed-dose combination medication used for the treatment of high cholesterol. [1][3] It is a combination of bempedoic acid and ezetimibe. [1][2] The most common side effects are hyperuricemia (high blood levels of uric acid) and constipation. [2]